Published in Adv Drug Deliv Rev on October 01, 2012
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol (2014) 2.75
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release (2013) 1.64
Enhancing anti-tumor efficacy of Doxorubicin by non-covalent conjugation to gold nanoparticles - in vitro studies on feline fibrosarcoma cell lines. PLoS One (2015) 1.40
Porphyrin-phospholipid liposomes permeabilized by near-infrared light. Nat Commun (2014) 1.20
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci (2013) 1.16
Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy. Nat Commun (2014) 1.11
Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. J Drug Deliv (2013) 1.06
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles. Mol Ther Nucleic Acids (2013) 1.05
State-of-the-art materials for ultrasound-triggered drug delivery. Adv Drug Deliv Rev (2013) 1.01
A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting. J Nucl Med (2014) 0.99
Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging. J Control Release (2014) 0.96
The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation. Int J Nanomedicine (2013) 0.95
Clinical Translation of Nanomedicine. Chem Rev (2015) 0.93
Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano (2014) 0.92
Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal. Proc Natl Acad Sci U S A (2014) 0.92
Advances and Challenges of Liposome Assisted Drug Delivery. Front Pharmacol (2015) 0.91
Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion. J Control Release (2014) 0.91
Surface engineering of liposomes for stealth behavior. Pharmaceutics (2013) 0.90
Harnessing photochemical internalization with dual degradable nanoparticles for combinatorial photo-chemotherapy. Nat Commun (2014) 0.89
Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display. Proc Natl Acad Sci U S A (2015) 0.88
Designer lipids for drug delivery: from heads to tails. J Control Release (2014) 0.88
The use of lipid-based nanocarriers for targeted pain therapies. Front Pharmacol (2013) 0.88
High-Density Lipoproteins: Nature's Multifunctional Nanoparticles. ACS Nano (2016) 0.87
Liposome-like Nanostructures for Drug Delivery. J Mater Chem B Mater Biol Med (2013) 0.87
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology (2014) 0.87
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond) (2015) 0.86
Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids Surf B Biointerfaces (2013) 0.86
Nano-engineered erythrocyte ghosts as inhalational carriers for delivery of fasudil: preparation and characterization. Pharm Res (2014) 0.86
Phototriggerable liposomes: current research and future perspectives. Pharmaceutics (2013) 0.86
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines. Oncotarget (2016) 0.86
Acid-degradable polymer-caged lipoplex (PCL) platform for siRNA delivery: facile cellular triggered release of siRNA. J Am Chem Soc (2013) 0.86
Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics (2013) 0.85
Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer. AAPS PharmSciTech (2014) 0.85
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery. Adv Mater (2016) 0.84
Nanoparticles: Pushed off target with proteins. Nat Nanotechnol (2013) 0.84
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings. J Control Release (2013) 0.84
Aptamers: active targeting ligands for cancer diagnosis and therapy. Theranostics (2015) 0.84
Self-assembly of size-controlled liposomes on DNA nanotemplates. Nat Chem (2016) 0.83
Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities. Chem Eng Sci (2015) 0.83
Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery. Int J Nanomedicine (2014) 0.83
Octanol-assisted liposome assembly on chip. Nat Commun (2016) 0.83
Ligation strategies for targeting liposomal nanocarriers. Biomed Res Int (2014) 0.83
Nanoparticle-based drug delivery to the vagina: a review. J Control Release (2014) 0.83
Liposomes in tissue engineering and regenerative medicine. J R Soc Interface (2014) 0.82
Therapeutic surfactant-stripped frozen micelles. Nat Commun (2016) 0.82
Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. J Nanobiotechnology (2013) 0.82
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges. Int J Nanomedicine (2015) 0.82
Well-defined single polymer nanoparticles for the antibody-targeted delivery of chemotherapeutic agents. Polym Chem (2015) 0.82
Synthetic Strategies for Engineering Intravenous Hemostats. Bioconjug Chem (2015) 0.82
Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion. Int J Nanomedicine (2014) 0.82
Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging. Nanomedicine (Lond) (2014) 0.81
Applications of nanoparticles for diagnosis and therapy of cancer. Br J Radiol (2015) 0.81
Lipoproteins and lipoprotein mimetics for imaging and drug delivery. Adv Drug Deliv Rev (2016) 0.81
Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.81
A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation. Drug Des Devel Ther (2015) 0.81
Liposomal delivery and polyethylene glycol-liposomal oxaliplatin for the treatment of colorectal cancer (Review). Biomed Rep (2014) 0.81
Enhanced localization of anticancer drug in tumor tissue using polyethylenimine-conjugated cationic liposomes. Nanoscale Res Lett (2014) 0.81
Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy. Crit Rev Oncog (2014) 0.81
Phospholipid-polymer amphiphile hybrid assemblies and their interaction with macrophages. Biomicrofluidics (2015) 0.81
Application of liposomal technologies for delivery of platinum analogs in oncology. Int J Nanomedicine (2013) 0.81
Liposome production by microfluidics: potential and limiting factors. Sci Rep (2016) 0.81
Ionic Driven Embedment of Hyaluronic Acid Coated Liposomes in Polyelectrolyte Multilayer Films for Local Therapeutic Delivery. Sci Rep (2015) 0.80
A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors. Nano Today (2013) 0.80
SapC-DOPS nanovesicles as targeted therapy for lung cancer. Mol Cancer Ther (2015) 0.80
The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo. Int J Mol Sci (2014) 0.80
Nonionic surfactant vesicles for delivery of RNAi therapeutics. Nanomedicine (Lond) (2013) 0.80
Engineering protocells: prospects for self-assembly and nanoscale production-lines. Life (Basel) (2015) 0.80
Systematic engineering of uniform, highly efficient, targeted and shielded viral-mimetic nanoparticles. Small (2013) 0.80
Direct and sustained intracellular delivery of exogenous molecules using acoustic-transfection with high frequency ultrasound. Sci Rep (2016) 0.80
Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy. Mol Ther (2016) 0.79
Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep (2016) 0.79
Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals. J Aerosol Med Pulm Drug Deliv (2015) 0.79
The Theranostic Path to Personalized Nanomedicine. Clin Transl Imaging (2014) 0.79
Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities. Adv Drug Deliv Rev (2015) 0.79
Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor. J Surg Res (2014) 0.79
Lasing in Live Mitotic and Non-Phagocytic Cells by Efficient Delivery of Microresonators. Sci Rep (2017) 0.79
Quantitative imaging of light-triggered doxorubicin release. Biomed Opt Express (2015) 0.78
The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice. Clin Vaccine Immunol (2015) 0.78
Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment. Int J Nanomedicine (2016) 0.78
Novel antigen delivery systems. World J Virol (2015) 0.78
Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice. PLoS One (2015) 0.78
Phospholipase A2-responsive antibiotic delivery via nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Mater Chem B Mater Biol Med (2014) 0.78
Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis. Adv Healthc Mater (2015) 0.78
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines. Nanomedicine (2015) 0.78
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries. Int J Nanomedicine (2014) 0.78
Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan. J Control Release (2014) 0.78
Characterization of nanoparticle delivery in microcirculation using a microfluidic device. Microvasc Res (2014) 0.78
Microfluidic remote loading for rapid single-step liposomal drug preparation. Lab Chip (2014) 0.78
Bioinspired membrane-based systems for a physical approach of cell organization and dynamics: usefulness and limitations. Interface Focus (2015) 0.78
Design strategies and applications of circulating cell-mediated drug delivery systems. ACS Biomater Sci Eng (2015) 0.78
Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle. MAbs (2015) 0.78
Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines. Integr Cancer Sci Ther (2015) 0.78
Chemically triggered release of 5-aminolevulinic acid from liposomes. RSC Adv (2014) 0.78
Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cells. Mol Pharm (2013) 0.78
Lipid Nanoparticle Systems for Enabling Gene Therapies. Mol Ther (2017) 0.77
Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes. Mol Ther (2017) 0.77
Mitochondria-targeting particles. Nanomedicine (Lond) (2014) 0.77
The immunological enhancement activity of propolis flavonoids liposome in vitro and in vivo. Evid Based Complement Alternat Med (2014) 0.77
The Density Code for the Development of a Vaccine? J Pharm Sci (2016) 0.77
Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin. Autophagy (2016) 0.77
Drug delivery systems: entering the mainstream. Science (2004) 9.27
Rational design of cationic lipids for siRNA delivery. Nat Biotechnol (2010) 4.97
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed Engl (2012) 1.87
The liposomal formulation of doxorubicin. Methods Enzymol (2005) 1.62
Liposomal nanomedicines. Expert Opin Drug Deliv (2008) 1.26
Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther (2011) 1.23
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA. Mol Ther Nucleic Acids (2012) 1.16
Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing. Langmuir (2012) 1.13
Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. J Control Release (2005) 1.12
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochim Biophys Acta (2006) 1.04
Liposomal nanomedicines: an emerging field. Toxicol Pathol (2008) 1.01
Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core. J Phys Chem C Nanomater Interfaces (2012) 0.93
Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain. Mol Ther Nucleic Acids (2013) 0.92
Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. J Pharm Sci (2005) 0.92
Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention. J Control Release (2005) 0.91
Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin. Biochim Biophys Acta (2007) 0.90
Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo. Int J Cancer (2012) 0.90
Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles. Int Immunol (2009) 0.90
Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles. Int Immunopharmacol (2007) 0.89
Synthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cells. Bioconjug Chem (2009) 0.88
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles. ACS Nano (2015) 0.88
Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids. Biochim Biophys Acta (2003) 0.87
Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles. J Control Release (2010) 0.87
Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. J Liposome Res (2008) 0.86
Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods Enzymol (2002) 0.86
Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics (2013) 0.85
Entrapment of small molecules and nucleic acid-based drugs in liposomes. Methods Enzymol (2005) 0.84
Tunable pH-sensitive liposomes. Methods Enzymol (2004) 0.83
Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA. Biochem J (2007) 0.83
Preparation, characterization, and biological analysis of liposomal formulations of vincristine. Methods Enzymol (2005) 0.82
Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents. Mol Membr Biol (2005) 0.82
Triggered release of doxorubicin following mixing of cationic and anionic liposomes. Biochim Biophys Acta (2002) 0.81
Calcium enhances the transfection potency of stabilized plasmid-lipid particles. Anal Biochem (2005) 0.80
Distal cationic poly(ethylene glycol) lipid conjugates in large unilamellar vesicles prepared by extrusion enhance liposomal cellular uptake. J Liposome Res (2004) 0.80
Development of high-concentration lipoplexes for in vivo gene function studies in vertebrate embryos. Dev Dyn (2011) 0.79
The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine. J Gene Med (2009) 0.78
Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA. Nanomedicine (2012) 0.78
Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA. Nanomedicine (2012) 0.77
Synthesis and properties of novel tetraalkyl cationic lipids. Bioconjug Chem (2002) 0.77
Capillary electrophoresis frontal analysis for characterization of alphavbeta3 integrin binding interactions. Anal Chem (2008) 0.77
IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice. Endocrinology (2014) 0.76
Investigation of factors responsible for cell line cytoplasmic expression differences. BMC Mol Biol (2005) 0.75
The effect of circulation lifetime and drug-to-lipid ratio of intravenously administered lipid nanoparticles on the biodistribution and immunostimulatory activity of encapsulated CpG-ODN. J Drug Target (2008) 0.75
Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications. Methods Mol Biol (2014) 0.75
Rapid synthesis of lipid nanoparticles containing hydrophobic inorganic nanoparticles. Nanoscale (2017) 0.75